Comparative Evaluation of Current Biochemical-, Sequencing-, and Proteomic-Based Identification Methods for the...

Area of Science:

• Clinical microbiology
• Bacterial identification
• Diagnostic platforms

Background:

• The Streptococcus bovis group comprises seven species/subspecies.
• Accurate identification is critical due to associations with serious conditions like gastrointestinal carcinoma and bacteremia.
• Current identification platforms in the U.S. exhibit limitations and inconsistencies.

Purpose of the Study:

• To compare the performance of various identification platforms for the Streptococcus bovis group.
• To determine the most accurate methods for definitive identification within this clinically significant group.

Main Methods:

• Evaluation of standard biochemical methods (Trek GPID, Vitek 2 GPID).
• Assessment of sequencing techniques (16S rDNA, sodA) with multiple databases (NCBI, RDP, CDC MicrobeNet).
• Comparison of MALDI-TOF MS platforms (Vitek MS, Bruker Biotyper MS) using eight type strains and 65 clinical isolates.

Main Results:

• No single platform achieved definitive identification for all S. bovis group type strains.
• Vitek MS demonstrated the highest accuracy (85.7%), followed by sodA sequencing (75%).
• Vitek 2 and Bruker Biotyper RUO showed moderate performance (62.5%), while other methods were significantly less effective.

Conclusions:

• Existing identification platforms have limitations in differentiating S. bovis group organisms.
• Vitek MS and sodA sequencing are recommended for more accurate identification.
• Awareness of these limitations and use of reflex testing are advised for clinicians and laboratorians.